Tag: FDA adverse event reporting
The FDA monitors generic drug safety after approval through real-time reporting, manufacturing data, and patient feedback. Learn how adverse events are tracked, what gaps exist, and what’s changing in 2025 to improve detection of quality and effectiveness issues.
Medications
Archives
Recent-posts
How to Talk about Stopping or Tapering a Medication Safely
Feb, 18 2026
Packaging and Labeling: How to Verify the Authenticity of Generic Medicines
Jan, 15 2026
Azathioprine and Allopurinol Interaction: Managing Toxic Metabolite Accumulation
Apr, 16 2026
Medication-Induced Acute Angle-Closure Glaucoma: Recognizing the Eye Emergency
Apr, 4 2026
Exploring Vibramycin Alternatives: A Look at Other Options
Mar, 20 2025